Patent · US Active

Methods for treatment of recurrent hematological malignancies

US9844593B2 · kind B2 · utility

2Cited by

1References

10Claims

0Family size

Assignee

INNATE PHARMA · FR

Inventors

Pascale Andre · Marseilles, FR
RENAUD BUFFET · Boulogne, FR
Marcel Rozencweig · Princeton, US
Jerome Tiollier · Val-de-Reuil, FR

Key dates

Filing date	Nov 22, 2011
Grant date	Dec 19, 2017
Priority date	—
Expiry date	Nov 22, 2031

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions comprising compounds that neutralize NK cell inhibitory receptors and methods of using such compositions in the treatment of hematological malignancies are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.